Fig. 4From: Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort studyNew users: Unadjusted probability of remaining on treatment. Wilcoxon p-value < 0.0001Back to article page